An overview of Alzheimer's disease

Journal of the Chinese Institute of Chemical Engineers

Volumn 36, Issue 6, 2005, Pages 533-559

  Wang, Steven S S ^a   Good, Theresa A ^b  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b Baltimore County   (United States)

Author keywords

amyloid; Aggregation; Alzheimer's disease; Amyloidosis; Fibril

Indexed keywords

BRAIN; DIAGNOSIS; MOLECULAR BIOLOGY; PATHOLOGY; PROTEINS; TOXICITY;

ALZHEIMER DISEASE; FIBRIL; NEUROTOXICITY; PATHOLOGICAL DEPOSITS; PRIMARY SEQUENCE HOMOLOGY;

DISEASES;

BRAIN; DIAGNOSIS; DISEASES; MOLECULAR BIOLOGY; PATHOLOGY; PROTEINS; TOXICITY;

EID: 32344453133     PISSN: 03681653     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (301)

1. Aisen, P. S., "Inflammation and Alzheimer Disease," Mol. Chem. Neuropathol., 28(1-3), 83 (1996).
2. Akiyama, H., K. Ikeda, H. Kondo, M. Kato, and P. L. McGeer, "Microglia Express the Type 2 Plasminogen Activator Inhibitor in the Brain of Control Subjects and Patients with Alzheimer's Disease," Neurosci. Lett., 164(1-2), 233 (1993).
3. Aksenov, M., M. V. Aksenova, M. E. Harris, K. Hensley, D. A. Butterfield, and J. M. Carney, "Enhancement of Beta-Amyloid Peptide A Beta(1-40)-Mediated Neurotoxicity by Glutamine Synthetase," J. Neurochem., 65(4), 1899 (1995).
4. Alzheimer, A., "Uber Eine Eigenartige Erkrangkung der Hirnrinde,: All. Z. Psychiatr., 64, 146 (1907).
5. Ariga, T. and R. K. Yu, "GM1 Inhibits Amyloid Beta-Protein-Induced Cytokine Release," Neurochem. Res., 24(2), 219 (1999).
6. Ariga, T., K. Kobayashi, A. Hasegawa, M. Kiso, H. Ishida, and T. Miyatake, "Characterization of High-Affinity Binding between Gangliosides and Amyloid Beta-Protein," Arch. Biochem. Biophys., 388(2), 225 (2001).
7. Arispe, N., H. B. Pollard, and E. Rojas, "Giant Multilevel Cation Channels Formed by Alzheimer Disease Amyloid Beta-Protein [A beta P-(1-40)] in Bilayer Membranes," Proc. Natl. Acad. Sci. USA., 90(22), 10573 (1993a).
8. Arispe, N., E. Rojas, and H. B. Pollard, "Alzheimer Disease Amyloid Beta Protein Forms Calcium Channels in Bilayer Membranes: Blockade by Tromethamine and Aluminum," Proc. Natl. Acad. Sci. U.S.A., 90(2), 567 (1993b).
9. 2+ Channels Provides a Mechanism for Neuronal Death in Alzheimer's Disease," Ann. N. Y. Acad. Sci., 747, 256 (1994a).
10. Arispe, N., H. B. Pollard, and E. Rojas, "Beta-Amyloid Ca(2+)-Channel Hypothesis for Neuronal Death in Alzheimer Disease," Mol. Cell. Biochem., 140(2), 119 (1994b).
11. 2+ Interaction with Alzheimer Amyloid Beta Protein Calcium Channels," Proc. Natl. Acad. Sci. U.S.A., 93(4), 1710 (1996).
12. Avdulov, N. A., S. V. Chochina, U. Igbavboa, E. O. O'Hare, F. Schroeder, J. P. Cleary, and W. G. Wood, "Amyloid Beta-Peptides Increase Annular and Bulk Fluidity and Induce Lipid Peroxidation in Brain Synaptic Plasma Mmbranes," J. Neurochem., 68(5), 2086 (1997).
13. Avdulov, N. A., S. V. Chochina, U. Igbavboa, C. S. Warden, F. Schroeder, and W. G. Wood, "Lipid Binding to Sterol Carrier Protein-2 is Inhibited by Ethanol," Biochim. Biophys. Acta., 1437(1), 37 (1999).
14. Bamberger, M. E. and G. E. Landreth, "Microglial Interaction with Beta-Amyloid: Implications for the Pathogenesis of Alzheimer's Disease," Microsc. Res. Tech., 54(2), 59 (2001).
15. Bard, F., C. Cannon, R. Barbour, R. L. Burke, D. Games, H. Grajeda, T. Guido, K. Hu, J. Huang, K. Johnson-Wood, K. Khan, D. Kholodenko, M. Lee, I. Lieberburg, R. Motter, M. Nguyen, F. Soriano, N. Vasquez, K. Weiss, B. Welch, P. Seubert, D. Schenk, and T. Yednock, "Peripherally Administered Antibodies Against Amyloid Beta-Peptide Enter the Central Nervous System and Reduce Pathology in a Mouse Model of Alzheimer Disease," Nat. Med., 6(8), 916 (2000).
16. Barger, S. W., "An Unconventional Hypothesis of Oxidation in Alzheimer's Disease: Intersections with Excitotoxicity," Front Biosci, 9, 3286 (2004).
17. Barrow, C. J. and M. G. Zagorski, "Solution Structures of Beta Peptide and Its Constituent Fragments: Relation to Amyloid Deposition," Science, 253(5016), 179 (1991).
18. Barrow, C. J., A. Yasuda, P. T. Kenny, and M. G. Zagorski, "Solution Conformations and Aggregational Properties of Synthetic Amyloid Beta-Peptides of Alzheimer's Disease. Analysis of Circular Dichroism Spectra," J. Mol. Biol., 225(4), 1075 (1992).
19. Behl, C., M. Widmann, T. Trapp, and F. Holsboer, "17-Beta Estradiol Protects Neurons from Oxidative Stress-Induced Cell Death In Vitro," Biochem. Biophys. Res. Commun., 216(2), 473 (1995).
20. +2 and Sheet Breakers on Aggregation of Amyloid Peptides," Protein Pept. Lett., 12(2), 197 (2005).
21. Blanchard, B. J., V. L. Thomas, and V. M. Ingram, "Mechanism of Membrane Depolarization Caused by the Alzheimer Abeta1-42 Peptide," Biochem. Biophys. Res. Commun., 293(4), 1197 (2002).
22. Bodovitz, S. and W. L. Klein, "Cholesterol Modulates Alpha-Secretase Cleavage of Amyloid Precursor Protein," J. Biol. Chem., 271(8), 4436 (1996).
23. Bornemann, K. D. and M. Staufenbiel, "Transgenic Mouse Models of Alzheimer's Disease," Ann. N. Y. Acad. Sci., 908, 260 (2000).
24. Bourne, H. R., D. A. Sanders, and F. McCormick, "The GTPase Superfamily: A Conserved Switch for Diverse Cell Functions," Nature, 348(6297), 125 (1990a).
25. Bourne, H. R., L. Wrischnik, and C. Kenyon, "Ras Proteins. Some Signal Developments," Nature, 348(6303), 678 (1990b).
26. Bradt, B. M., W. P. Kolb, and N. R. Cooper, "Complement-Dependent Proinflammatory Properties of the Alzheimer's Disease Beta-Peptide," J. Exp. Med., 188(3), 431 (1998).
27. Bretscher, M. S. and S. Munro, "Cholesterol and the Golgi Apparatus," Science, 261(5126), 1280 (1993).
28. Broytman, O. and J. S. Malter, "Anti-Abeta: The Good, the Bad, and the Unforeseen," J. Neurosci. Res., 75(3), 301 (2004).
29. Burdick, D., B. Soreghan, M. Kwon, J. Kosmoski, M. Knauer, A. Henschen, J. Yates, C. Cotman, and C. Glabe, "Assembly and Aggregation Properties of Synthetic Alzheimer's A4/beta Amyloid Peptide Analogs," J. Biol. Chem., 267(1), 546 (1992).
30. Burggren, A. C. and S. Y. Bookheimer, "Structural and Functional Neuroimaging in Alzheimer's Disease: An Update," Curr. Top. Med. Chem., 2(4), 385 (2002).
31. Busciglio, J., J. Yeh, and B. A. Yankner, "Beta-Amyloid Neurotoxicity in Human Cortical Culture is not Mediated by Excitotoxins," J. Neurochem., 61(4), 1565 (1993).
32. Butterfield, D. A., K. Hensley, M. Harris, M. Mattson, and J. Carney, "Beta-Amyloid Peptide Free Radical Fragments Initiate Synaptosomal Lipoperoxidation in a Sequence-Specific Fashion: Implications to Alzheimer's Disease," Biochem. Biophys. Res. Commun., 200(2), 710 (1994).
33. Butterfield, D. A., "Beta-Amyloid-Associated Free Fadical Oxidative Stress and Neurotoxicity: Implications for Alzheimer's Disease," Chem. Res. Toxicol., 10(5), 495 (1997).
34. Butterfield, D. A., S. M. Yatin, S. Varadarajan, and T. Koppal, "Amyloid Beta-Peptide-Associated Free Radical Oxidative Stress, Neurotoxicity, and Alzheimer's Disease," Methods Enzymol., 309, 746 (1999).
35. Buxbaum, J. D., M. Oishi, H. I. Chen, R. Pinkas-Kramarski, E. A. Jaffe, S. E. Gandy, and P. Greengard, "Cholinergic Agonists and Interleukin 1 Regulate Processing and Secretion of the Alzheimer Beta/A4 Amyloid Protein Precursor," Proc. Natl. Acad. Sci. U.S.A., 89(21), 10075 (1992).
36. Caporaso, G. L., S. E. Gandy, J. D. Buxbaum, T. V. Ramabhadran, and P. Greengard, "Protein Phosphorylation Regulates Secretion of Alzheimer Beta/A4 Amyloid Precursor Protein," Proc. Natl. Acad. Sci. U.S.A., 89(7), 3055 (1992).
37. Carr, D. B., A. Goate, D. Phil, and J. C. Morris, "Current Concepts in the Pathogenesis of Alzheimer's Disease," Am. J. Med., 103(3A), 3S (1997).
38. Carrell, R. W. and D. A. Lomas, "Conformational Disease [see comments]," Lancet, 350(9071), 134 (1997).
39. Carrell, R. W. and B. Gooptu, "Conformational Changes and Disease-Serpins, Prions and Alzheimer's," Curr. Opin. Struct. Biol., 8(6), 799 (1998).
40. Chapman, P. F., G. L. White, M. W. Jones, D. Cooper-Blacketer, V. J. Marshall, M. Irizarry, L. Younkin, M. A. Good, T. V. Bliss, B. T. Hyman, S. G. Younkin, and K. K. Hsiao, "Impaired Synaptic Plasticity and Learning in Aged Amyloid Precursor Protein Transgenic Mice," Nat. Neurosci., 2(3), 271 (1999).
41. Chochina, S. V., N. A. Avdulov, U. Igbavboa, J. P. Cleary, E. O. O'Hare, and W. G. Wood, "Amyloid Beta-Peptide1-40 Increases Neuronal Membrane Fluidity: Role of Cholesterol and Brain Region,: J. Lipid. Res., 42(8), 1292 (2001).
42. Choo-Smith, L. P., W. Garzon-Rodriguez, C. G. Glabe, and W. K. Surewicz, "Acceleration of Amyloid Fibril Formation by Specific Binding of Abeta- (1-40) Peptide to Ganglioside-Containing Membrane Vesicles," J. Biol. Chem., 272(37), 22987 (1997).
43. Chromy, B. A., R. J. Nowak, M. P. Lambert, K. L. Viola, L. Chang, P. T. Velasco, B. W. Jones, S. J. Fernandez, P. N. Lacor, P. Horowitz, C. E. Finch, G. A. Krafft, and W. L. Klein, "Self-Assembly of Abeta(1-42) into Globular Neurotoxins," Biochemistry, 42(44), 12749 (2003).
44. Ciccotosto, G. D., D. Tew, C. C. Curtain, D. Smith, D. Carrington, C. L. Masters, A. I. Bush, R. A. Cherny, R. Cappai, and K. J. Barnham, "Enhanced Toxicity and Cellular Binding of a Modified Amyloid Beta Peptide with a Methionine to Valine Substitution," J. Biol. Chem., 279(41), 42528 (2004).
45. Cole, G. M., T. Morihara, G. P. Lim, F. S. Yang, A. Begum, and S. A. Frautschy, NSAID and Antioxidant Prevention of Alzheimer's Disease Lessons from In Vitro and Animal Models, In Protective Strategies for Neurodegenerative Diseases, p. 68 (2004).
46. Coles, M., W. Bicknell, A. A. Watson, D. P. Fairlie, and D. J. Craik, "Solution Structure of Amyloid Beta-Peptide(1-40) in a Water-Micelle Environment. Is the Membrane-Spanning Domain Where We Think It Is?," Biochemistry, 37(31), 11064 (1998).
47. Corder, E. H., A. M. Saunders, W. J. Strittmatter, D. E. Schmechel, P. C. Gaskell, G. W. Small, A. D. Roses, J. L. Haines, and M. A. Pericak-Vance, "Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset Families," Science, 261(5123), 921 (1993).
48. Crescenzi, O., S. Tomaselli, R. Guerrini, S. Salvadori, A. M. D'Ursi, P. A. Temussi, and D. Picone, "Solution Structure of the Alzheimer Amyloid Beta-Peptide (1-42) in an Apolar Microenvironment. Similarity with a Virus Fusion Domain," Eur. J. Biochem., 269(22), 5642 (2002).
49. Cribbs, D. H., C. J. Pike, S. L. Weinstein, P. Velazquez, and C. W. Cotman, "All-D-enantiomers of Beta-Amyloid Exhibit Similar Biological Properties to All-L-Beta-Amyloids," J. Biol. Chem., 272(11), 7431 (1997).
50. Cummings, B. J., C. J. Pike, R. Shankle, and C. W. Cotman, "Beta-Amyloid Deposition and Other Measures of Neuropathology Predict Cognitive Status in Alzheimer's Disease," Neurobiol. Aging., 17(6), 921 (1996).
51. Czech, C., H. Forstl, F. Hentschel, U. Monning, C. Besthorn, C. Geiger-Kabisch, H. Sattel, C. Masters, and K. Beyreuther, "Apolipoprotein E-4 Gene Dose in Clinically Diagnosed Alzheimer's Disease: Prevalence, Plasma Cholesterol Levels and Cerebrovascular Change," Eur. Arch. Psychiatry Clin. Neurosci., 243(5), 291 (1994).
52. Datki, Z., A. Juhasz, M. Galfi, K. Soos, R. Papp, D. Zadori, and B. Penke, "Method for Measuring Neurotoxicity of Aggregating Polypeptides with the MTT Assay on Differentiated Neuroblastoma Cells," Brain. Res. Bull., 62(3), 223 (2003).
53. Datki, Z., R. Papp, D. Zadori, K. Soos, L. Fulop, A. Juhasz, G. Laskay, C. Hetenyi, E. Mihalik, M. Zarandi, and B. Penke, "In vitro model of Neurotoxicity of Abeta 1-42 and Neuroprotection by a Pentapeptide: Irreversible Events during the First Hour," Neurobiol. Dis., 17(3), 507 (2004).
54. Davis, J. B., H. F. McMurray, and D. Schubert, "The Amyloid Beta-Protein of Alzheimer's Disease is Chemotactic for Mononuclear Phagocytes*: Biochem. Biophys. Res. Commun., 189(2), 1096 (1992).
55. Davis, J. B., "Oxidative Mechanisms in Beta-Amyloid Cytotoxicity," Neurodegeneration, 5(4), 441 (1996).
56. De Felice, F. G., M. N. Vieira, L. M. Saraiva, J. D. Figueroa-Villar, J. Garcia-Abreu, R. Liu, L. Chang, W. L. Klein, and S. T. Ferreira, "Targeting the Neurotoxic Species in Alzheimer's Disease: Inhibitors of Abeta Oligomerization," Faseb. J., 18(12), 1366 (2004).
57. Del Mar Martinez-Senac, M., J. Villalain, and J. C. Gomez-Fernandez, "Structure of the Alzheimer Beta-Amyloid Peptide (25-35) and Its Interaction with Negatively Charged Phospholipid Vesicles," Eur. J. Biochem., 265(2), 744 (1999).
58. Delobette, S., A. Privat, and T. Maurice, "In Vitro Aggregation Facilities Beta-Amyloid Peptide-(25-35)-Induced Amnesia in the Rat," Eur. J. Pharmacol., 319(1), 1 (1997).
59. DeMattos, R. B., K. R. Bales, D. J. Cummins, J. C. Dodart, S. M. Paul, and D. M. Holtzman, "Peripheral Anti-A Beta Antibody Alters CNS and Plasma A Beta Clearance and Decreases Brain A Beta Burden in a Mouse Model of Alzheimer's Disease," Proc. Natl. Acad Sci. U.S.A., 98(15), 8850 (2001).
60. Demeester, N., G. Baier, C. Enzinger, M. Goethals, J. Vandekerckhove, M. Rosseneu, and C. Labeur, "Apoptosis Induced in Neuronal Cells by C-Terminal Amyloid Beta-Fragments is Correlated with Their Aggregation Properties in Phospholipid Membranes," Mol. Membr. Biol., 17(4), 219 (2000).
61. Demeester, N., C. Mertens, H. Caster, M. Goethals, J. Vandekerckhove, M. Rosseneu, and C. Labeur, "Comparison of the Aggregation Properties, Secondary Structure and Apoptotic Effects of Wild-Type, Flemish and Dutch N-Terminally Truncated Amyloid Beta Peptides," Eur. J. Neurosci., 13(11), 2015 (2001).
62. Dobson, C. M., "Principles of Protein Folding, Misfolding and Aggregation," Semin. Cell. Dev. Biol., 15(1), 3 (2004).
63. Durham, R. A., C. A. Parker, M. R. Emmerling, C. L. Bisgaier, and L. C. Walker, "Effect of Age and Diet on the Expression of Beta-Amyloid 1-40 and 1-42 in the Brains of Apolipoprotein-E-Deficient Mice," Neurobiol. Aging., 19, S281 (1998).
64. Dyrks, T., A. Weidemann, G. Multhaup, J. M. Salbaum, H. G. Lemaire, J. Kang, B. Muller-Hill, C. L. Masters, and K. Beyreuther, "Identification, Transmembrane Orientation and Biogenesis of the Amyloid A4 Precursor of Alzheimer's Disease," Embo. J., 7(4), 949 (1988).
65. El-Agnaf, O. M., D. J. Guthrie, D. M. Walsh, and G. B. Irvine, "The Influence of the Central Region Containing Residues 19-25 on the Aggregation Properties and Secondary Structure of Alzheimer's Beta-Amyloid Peptide," Eur. J. Biochem., 256(3), 560 (1998).
66. El-Agnaf, O. M., D. S. Mahil, B. P. Patel, and B. M. Austen, "Oligomerization and Toxicity of Beta-Amyloid-42 Implicated in Alzheimer's Disease," Biochem. Biophys. Res. Commun., 273(3), 1003 (2000).
67. Emmerling, M. R., K. Spiegel, and M. D. Watson, "Inhibiting the Formation of Classical C3-Convertase on the Alzheimer's Beta-Amyloid Peptide," Immunopharmacology, 38(1-2), 101 (1997).
68. Esler, W. P., E. R. Stimson, J. R. Ghilardi, H. V. Vinters, J. P. Lee, P. W. Mantyh, and J. E. Maggio, "In Vitro Growth of Alzheimer's Disease Beta-Amyloid Plaques Displays First-Order Kinetics," Biochemistry, 35(3), 749 (1996).
69. Evans, R. M., C. L. Emsley, S. Gao, A. Sahota, K. S. Hall, M. R. Farlow, and H. Hendrie, "Serum Cholesterol, APOE Genotype, and the Risk of Alzheimer's Disease: a Population-Based Study of African Americans," Neurology, 54(1), 240 (2000).
70. Fassbender, K., M. Simons, C. Bergmann, M. Stroick, D. Lutjohann, P. Keller, H. Runz, S. Kuhl, T. Bertsch, K. von Bergmann, M. Hennerici, K. Beyreuther, and T. Hartmann, "Simvastatin Strongly Reduces Levels of Alzheimer's Disease Beta - Amyloid Peptides Abeta 42 and Abeta 40 in Vitro and In Vivo," Proc. Natl. Acad. Sci. U.S.A., 98(10), 5856 (2001).
71. Ferrari-DiLeo, G., D. C. Mash, and D. D. Flynn, "Attenuation of Muscarinic Receptor-G-Protein Interaction in Alzheimer Disease," Mol. Chem. Neuropathol., 24(1), 69 (1995).
72. Festy, F., L. Lins, G. Peranzi, J. N. Octave, R. Brasseur, and A. Thomas, "Is Aggregation of Beta-Amyloid Peptides a Mis-Functioning of a Current Interaction Process?," Biochim. Biophys. Acta., 1546(2), 356 (2001).
73. Fezoui, Y. And D. B. Teplow, "Kinetic Studies of Amyloid Beta-Protein Fibril Assembly. Differential Effects of Alpha-helix Stabilization," J. Biol. Chem., 277(40), 36948 (2002).
74. Fishman, C. E., S. L. White, C. A. DeLong, D. J. Cummins, W. H. Jordan, K. R. Bales, and S. M. Paul, "High Fat Diet Potentiates β-Amyloid Deposition in the APP V717F Transgenic Mouse Model of Alzheimer's Disease," Soc. Neurosci., 25, 1859 (1999).
75. Fraser, P. E., J. T. Nguyen, W. K. Surewicz, and D. A. Kirschner, "pH-Dependent Structural Transitions of Alzheimer Amyloid Peptides," Biophys. J., 60(5), 1190 (1991).
76. Fraser, P. E., D. R. McLachlan, W. K. Surewicz, C. A. Mizzen, A. D. Snow, J. T. Nguyen, and D. A. Kirschner, "Conformation and Fibrillogenesis of Alzheimer A Beta Peptides with Selected Substitution of Charged Residues," J. Mol. Biol., 244(1), 64 (1994).
77. Fraser, S. P., Y. H. Suh, and M. B. Djamgoz, "Ionic Effects of the Alzheimer's Disease Beta-Amyloid Precursor Protein and Its Metabolic Fragments," Trends. Neurosci., 20(2), 67 (1997).
78. Frears, E. R., D. J. Stephens, C. E. Walters, H. Davies, and B. M. Austen, "The Role of Cholesterol in the Biosynthesis of Beta-Amyloid," Neuroreport, 10(8), 1699 (1999).
79. Gabuzda, D., J. Busciglio, and B. A. Yankner, "Inhibition of Beta-Amyloid Production by Activation of Protein Kinase C," J. Neurochem., 61(6), 2326 (1993).
80. Galbete, J. L., T. R. Martin, E. Peressini, P. Modena, R. Bianchi, and G. Forloni, "Cholesterol Decreases Secretion of the Secreted Form of Amyloid Precursor Protein by Interfering with Glycosylation in the Protein Secretory Pathway," Biochem. J., 348 (2), 307 (2000).
81. Games, D., K. M. Khan, F. G. Soriano, P. S. Keim, D. L. Davis, K. Bryant, and I. Lieberburg, "Lack of Alzheimer Pathology after Beta-Amyloid Protein Injections in Rat Brain," Neurobiol. Aging., 13(5), 569 (1992).
82. Games, D., D. Adams, R. Alessandrini, R. Barbour, P. Berthelette, C. Blackwell, T. Carr, J. Clemens, T. Donaldson, F. Gillespie, "Alzheimer-Type Neuropathology in Transgenic Mice Overexpressing V717F Beta-Amyloid Precursor Protein," Nature, 373(6514), 523 (1995).
83. Garzon-Rodriguez, W., M. Sepulveda-Becerra, S. Milton, and C. G. Glabe, "Soluble Amyloid Abeta-(1-40) Exists as a Stable Dimer at Low Concentrations," J. Biol. Chem., 272(34), 21037 (1997).
84. Gilman, A. G., "G Proteins: Transducers of Receptor-Generated Signals," Annu. Rev. Biochem., 56, 615 (1987).
85. Ginsberg, L., J. R. Atack, S. I. Rapoport, and N. L. Gershfeld, "Regional Specificity of Membrane Instability in Alzheimer's Disease Brain," Brain Res., 615(2), 355 (1993).
86. Giovannelli, L., C. Scali, M. S. Faussone-Pellegrini, G. Pepeu, and F. Casamenti, "Long-Term Changes in the Aggregation State and Toxic Effects of Beta-Amyloid Injected into the Rat Brain," Neuroscience, 87(2), 349 (1998).
87. Golde, T. E. and C. B. Eckman, "Cholesterol Modulation as an Emerging Strategy for the Treatment of Alzheimer's Disease," Drug Discov. Today, 6(20), 1049 (2001).
88. Good, T. A., "The Aggregation State Specific Role of Beta-Amyloid Peptide in Neurotoxicity Associated with Alzheimer's Disease," In Department of Chemical Engineering. University of Wisconsin, Madison, p. 248 (1996).
89. + Current in Rat Hippocampal Neurons," Biophys. J., 70(1), 296 (1996).
90. Goodman, Y. and M. P. Mattson, "Secreted Forms of Beta-Amyloid Precursor Protein Protect Hippocampal Neurons Against Amyloid Beta-Peptide-Induced Oxidative Injury," Exp. Neurol., 128(1), 1 (1994a).
91. Goodman, Y. and M. P. Mattson, "Staurosporine and K-252 Compounds Protect Hippocampal Neurons Against Amyloid Beta-Peptide Toxicity and Oxidative Injury," Brain Res, 650(1), 170 (1994b).
92. Gotz, J., F. Chen, J. van Dorpe, and R. M. Nitsch, "Formation of Neurofibrillary Tangles in P3011 Tau Transgenic Mice Induced by Abeta 42 Fibrils," Science, 293(5534), 1491 (2001).
93. Graham, D. I., S. M. Gentleman, J. A. Nicoll, M. C. Royston, J. E. McKenzie, G. W. Roberts, R. E. Mrak, and W. S. Griffin, "Is There a Genetic Basis for the Deposition of Beta-Amyloid after Fatal Head Injury?," Cell. Mol. Neurobiol., 19(1), 19 (1999).
94. Gursky, O. and S. Aleshkov, "Temperature-Dependent Beta-Sheet Formation in Beta-Amyloid Abeta(1-40) Peptide in Water: Uncoupling Beta-Structure Folding from Aggregation," Biochim. Biophys. Acta., 1476(1), 93 (2000).
95. Haass, C., A. Y. Hung, M. G. Schlossmacher, T. Oltersdorf, D. B. Teplow, and D. J. Selkoe, "Normal Cellular Processing of the Beta-Amyloid Precursor Protein Results in the Secretion of the Amyloid Beta Peptide and Related Molecules," Ann. N. Y. Acad. Sci., 695, 109 (1993).
96. Hansson, H. A., J. Holmgren, and L. Svennerholm, "Ultrastructural Localization of Cell Membrane GM1 Ganglioside by Cholera Toxin," Proc. Natl. Acad. Sci. U.S.A., 74(9), 3782 (1977).
97. Hartley, D. M., D. M. Walsh, C. P. Ye, T. Diehl, S. Vasquez, P. M. Vassilev, D. B. Teplow, and D. J. Selkoe, "Protofibrillar Intermediates of Amyloid Beta-Protein Induce Acute Electrophysiological Changes and Progressive Neurotoxicity in Cortical Neurons," J. Neurosci., 19(20), 8876 (1999).
98. Hartmann, H., A. Eckert, and W. E. Muller, "Apolipoprotein E and Cholesterol Affect Neuronal Calcium Signalling: the Possible Relationship to Beta-Amyloid Neurotoxicity," Biochem. Biophys. Res. Commun., 200(3), 1185 (1994).
99. He, W. and C. J. Barrow, "The A Beta 3-Pyroglutamyl and 11-Pyroglutamyl Peptides Found in Senile Plaque Have Greater Beta-Sheet Forming and Aggregation Propensities In Vitro than Full-Length A Beta," Biochemistry, 38(33), 10871 (1999).
100. Hensley, K., J. M. Carney, M. P. Mattson, M. Aksenova, M. Harris, J. F. Wu, R. A. Floyd, and D. A. Butterfield, "A Model for Beta-Amyloid Aggregation and Neurotoxicity Based on free Radical Generation by the Peptide: Relevance to Alzheimer Disease," Proc. Nat. Acad. Sc. U.S.A., 91(8), 3270 (1994).
101. Hertel, C., E. Terzi, N. Hauser, R. Jakob-Rotne, J. Seelig, and J. A. Kemp, "Inhibition of the Electrostatic Interaction Between Beta-Amyloid Peptide and Membranes Prevents Beta-Amyloid-Induced Toxicity," Proc. Natl. Acad. Sci. U.S.A., 94(17), 9412 (1997).
102. Hilbich, C., B. Kisters-Woike, J. Reed, C. L. Masters, and K. Beyreuther, "Aggregation and Secondary Structure of Synthetic Amyloid Beta A4 Peptides of Alzheimer's Disease," J. Mol. Biol., 218(1), 149 (1991).
103. Hirakura, Y., M. C. Lin, and B. L. Kagan, "Alzheimer Amyloid Abeta1-42 Channels: Effects of Solvent, pH, and Congo Red," J. Neurosci. Res., 57(4), 458 (1999).
104. Holcomb, L., M. N. Gordon, E. McGowan, X. Yu, S. Benkovic, P. Jantzen, K. Wright, I. Saad, R. Mueller, D. Morgan, S. Sanders, C. Zehr, K. O'Campo, J. Hardy, C. M. Prada, C. Eckman, S. Younkin, K. Hsiao, and K. Duff, "Accelerated Alzheimer-Type Phenotype in Transgenic Mice Carrying Both Mutant Amyloid Precursor Protein and Presenilin 1 Transgenes," Nat. Med., 4(1), 97 (1998).
105. Holscher, C., "Possible Causes of Alzheimer's Disease: Amyloid Fragments, Free Radicals, and Calcium Homeostasis," Neurobiol. Dis., 5(3), 129 (1998).
106. Hoshi, M., M. Sato, S. Matsumoto, A. Noguchi, K. Yasutake, N. Yoshida, and K. Sato, "Spherical Aggregates of Beta-Amyloid (Amylospheroid) Show High Neurotoxicity and Activate Tau Protein Kinase I/Glycogen Synthase Kinase-3beta," Proc. Natl. Acad. Sci. U.S.A., 100(11), 6370 (2003).
107. Howland, D. S., S. P. Trusko, M. J. Savage, A. G. Reaume, D. M. Lang, J. D. Hirsch, N. Maeda, R. Siman, B. D. Greenberg, R. W. Scott, and D. G. Flood, "Modulation of Secreted Beta-Amyloid Precursor Protein and Amyloid Beta-Peptide in Brain by Cholesterol," J. Biol. Chem., 273(26), 16576 (1998).
108. Howlett, D. R., K. H. Jennings, D. C. Lee, M. S. Clark, F. Brown, R. Wetzel, S. J. Wood, P. Camilleri, and G. W. Roberts, "Aggregation State and Neurotoxic Properties of Alzheimer Beta-Amyloid Peptide," Neurodegeneration, 4(1), 23 (1995).
109. Hsia, A. Y., E. Masliah, L. McConlogue, G. Q. Yu, G. Tatsuno, K. Hu, D. Kholodenko, R. C. Malenka, R. A. Nicoll, and L. Mucke, "Plaque-Independent Disruption of Neural Circuits in Alzheimer's Disease Mouse Models," Proc. Natl. Acad. Sci. U.S.A., 96(6), 3228 (1999).
110. Hyman, B. T., G. W. van Horsen, A. R. Damasio, and C. L. Barnes, "Alzheimer's Disease: Cell-Specific Pathology Isolates the Hippocampal Formation," Science, 225(4667), 1168 (1984).
111. Imbimbo, B. P., "The Potential Role of Non-Steroidal Anti-inflammatory Drugs in Treating Alzheimer's Disease," Expert Opinion on Investigational Drugs, 13(11), 1469 (2004).
112. Inouye, H., P. E. Fraser, and D. A. Kirschner, "Structure of Beta-Crystallite Assemblies Formed by Alzheimer Beta-Amyloid Protein Analogues: Analysis by X-Ray Diffraction," Biophys. J., 64(2), 502 (1993).
113. Iqbal, K., C. Alonso Adel, E. El-Akkad, C. X. Gong, N. Haque, S. Khatoon, J. J. Pei, H. Tanimukai, I. Tsujio, J. Z. Wang, and I. Grundke-Iqba, "Alzheimer Neurofibrillary Degeneration: Therapeutic Targets and High-Throughput Assays," J. Mol. Neurosci., 20(3), 425 (2003).
114. Ishiura, S., "Proteolytic Cleavage of the Alzheimer's Disease Amyloid A4 Precursor Protein," J. Neurochem., 56(2), 363 (1991).
115. Iversen, L. L., R. J. Mortishire-Smith, S. J. Pollack, and M. S. Shearman, "The Toxicity In Vitro of Beta-Amyloid Protein," Biochem. J., 311(1), 1 (1995).
116. Jacchieri, S. G., "Study of Alpha-Helix to Beta-Strand to Beta-Sheet Transitions in Amyloid: the Role of Segregated Hydrophobic Beta-Strands," Biophys. Chem., 74(1), 23 (1998).
117. Janus, C., J. Pearson, J. McLaurin, P. M. Mathews, Y. Jiang, S. D. Schmidt, M. A. Chishti, P. Horne, D. Heslin, J. French, H. T. Mount, R. A. Nixon, M. Mercken, C. Bergeron, P. E. Fraser, P. St George-Hyslop, and D. Westaway, "A Beta Peptide Immunization Reduces Behavioural Impairment and Plaques in a Model of Alzheimer's Disease," Nature, 408(6815), 979 (2000).
118. Jarrett, J. T. and P. T. Lansbury, Jr., "Amyloid Fibril Formation Requires a Chemically Discriminating Nucleation Event: Studies of an Amyloidogenic Sequence from the Bacterial Protein OsmB," Biochemistry, 31(49), 12345 (1992).
119. Jarrett, J. T., E. P. Berger, and P. T. Lansbury, Jr., "The Carboxy Terminus of the Beta Amyloid Protein is Critical for the Seeding of Amyloid Formation: Implications for the Pathogenesis of Alzheimer's Disease," Biochemistry, 32(18), 4693 (1993).
120. Jarvik, G. P., E. M. Wijsman, W. A. Kukull, G. D. Schellenberg, C. Yu, and E. B. Larson, "Interactions of Apolipoprotein E Genotype, Total Cholesterol Level, Age, and Sex in Prediction of Alzheimer's Disease: A Case-Control Study," Neurology, 45(6), 1092 (1995).
121. Ji, S. R., Y. Wu, and S. F. Sui, "Study of the Correlation of Secondary Structure of Beta-Amyloid Peptide (Abeta40) with the Hydrophobic Exposure Under Different Conditions," Gen. Physiol. Biophys., 21(4), 415 (2002).
122. Johnson-Wood, K., M. Lee, R. Motter, K. Hu, G. Gordon, R. Barbour, K. Khan, M. Gordon, H. Tan, D. Games, I. Lieberburg, D. Schenk, P. Seubert, and L. McConlogue, "Amyloid Precursor Protein Processing and A Beta42 Deposition in a Transgenic Mouse Model of Alzheimer Disease," Proc. Natl. Acad. Sci. U.S.A., 94(4), 1550 (1997).
123. Jonsson, K. O., H. L. Hedin, and C. J. Fowler, "Investigation into the Rapid Effects of 17 Beta-Estradiol and Neuroactive Steroids Upon Beta-Amyloid(25-35)-Induced Activation of Phosphoinositide-Specific Phospholipase C in Human Platelets," Methods Find Exp Clin Pharmacol, 22(8), 615 (2000).
124. Kakio, A., S. I. Nishimoto, K. Yanagisawa, Y. Kozutsumi, and K. Matsuzaki, "Cholesterol-Dependent Formation of GM1 Ganglioside-Bound Amyloid Beta-Protein, an Endogenous Seed for Alzheimer Amyloid," J. Biol. Chem., 276(27), 24985 (2001).
125. Kakio, A., S. Nishimoto, K. Yanagisawa, Y. Kozutsumi, and K. Matsuzaki, "Interactions of Amyloid Beta-Protein with Various Gangliosides in Raft-Like Membranes: Importance of GM1 Ganglioside-Bound form as an Endogenous Seed for Alzheimer Amyloid," Biochemistry, 41(23), 7385 (2002).
126. Kang, J., H. G. Lemaire, A. Unterbeck, J. M. Salbaum, C. L. Masters, K. H. Grzeschik, G. Multhaup, K. Beyreuther, and B. Muller-Hill, "The Precursor of Alzheimer's Disease Amyloid A4 Protein Resembles a Cell-Surface Receptor," Nature, 325(6106), 733 (1987).
127. Kawooya, J. K,, T. L. Emmons, P. A. Gonzalez-DeWhitt, M. C. Camp, and S. C. D'Andrea, "Electrophoretic Mobility of Alzheimer's Amyloid-Beta Peptides in Urea-Sodium Dodecyl Sulfate-Polyacrylamide Gel Electrophoresis," Anal. Biochem., 323(1), 103 (2003).
128. Kayed, R., E. Head, J. L. Thompson, T. M. McIntire, S. C. Milton, C. W. Cotman, and C. G. Glabe, "Common Structure of Soluble Amyloid Oligomers Implies Common Mechanism of Pathogenesis," Science, 300(5618), 486 (2003).
129. Kelly, J. W., "The Alternative Conformations of Amyloidogenic Proteins and Their Multi-Step Assembly Pathways," Curr. Opin. Struct. Biol., 8(1), 101 (1998a).
130. Kelly, J. W., "The Environmental Dependency of Protein Folding Best Explains Prion and Amyloid Diseases," Proc. Natl. Acad. Sci. U.S.A., 95(3), 930 (1998b).
131. Kheterpal, I., S. Zhou, K. D. Cook, and R. Wetzel, "Abeta Amyloid Fibrils Possess a Core Structure Highly Resistant to Hydrogen Exchange," Proc. Natl. Acad. Sci. U.S.A., 97(25), 13597 (2000).
132. Kheterpal, I., A. Williams, C. Murphy, B. Bledsoe, and R. Wetzel, "Structural Features of the Abeta Amyloid Fibril Elucidated by Limited Proteolysis," Biochemistry, 40(39), 11757 (2001).
133. Kheterpal, I., H. A. Lashuel, D. M. Hartley, T. Walz, P. T. Lansbury, Jr., and R. Wetzel, "Abeta Protofibrils Possess a Stable Core Structure Resistant to Hydrogen Exchange," Biochemistry, 42(48), 14092 (2003a).
134. Kheterpal, I., R. Wetzel, and K. D. Cook, "Enhanced Correction Methods for Hydrogen Exchange-Mass Spectrometric Studies of Amyloid Fibrils," Protein. Sci., 12(3), 635 (2003b).
135. Kilsdonk, E. P., P. G. Yancey, G. W. Stoudt, F. W. Bangerter, W. J. Johnson, M. C. Phillips, and G. H. Rothblat, "Cellular Cholesterol Efflux Mediated by Cyclodextrins," J. Biol. Chem., 270(29), 17250 (1995).
136. Kitaguchi, N., Y. Takahashi, Y. Tokushima, S. Shiojiri, and H. Ito, "Novel Precursor of Alzheimer's Disease Amyloid Protein Shows Protease Inhibitory Activity," Nature, 331(6156), 530 (1988).
137. Klein, I., L. Moore, and I. Pastan, "Effect of Liposomes Containing Cholesterol on Adenylate Cyclase Activity of Cultured Mammalian Fibroblasts," Biochim. Biophys. Acta., 506(1), 42 (1978).
138. Klein, U., G. Gimpl, and F. Fahrenholz, "Alteration of the Myometrial Plasma Membrane Cholesterol Content with Beta-Cyclodextrin Modulates the Binding Affinity of the Oxytocin Receptor," Biochemistry, 34(42), 13784 (1995).
139. Klein, W. L., G. A. Krafft, and C. E. Finch, "Targeting Small Abeta Oligomers: the Solution to an Alzheimer's Disease Conundrum?" Trends Neurosci., 24(4), 219 (2001).
140. Klein, W. L., W. B. Stine, Jr., and D. B. Teplow, "Small Assemblies of Unmodified Amyloid Beta-Protein are the Proximate Neurotoxin in Alzheimer's Disease," Neurobiol. Aging., 25(5), 569 (2004).
141. Kohno, T., K. Kobayashi, T. Maeda, K. Sato, and A. Takashima, "Three-Dimensional Structures of the Amyloid Beta Peptide (25-35) in Membrane-Mimicking Environment," Biochemistry, 35(50), 16094 (1996).
142. Kourie, J. I., C. L. Henry, and P. Farrelly, "Diversity of Amyloid Beta Protein Fragment [1-40]-Formed Channels," Cell. Mol. Neurobiol., 21(3), 255 (2001).
143. Kowalska, A., D. Pruchnik-Wolinska, J. Florczak, R. Modestowicz, J. Szczech, W. Kozubski, G. Rossa, and M. Wender, "Genetic Study of Familial Cases of Alzheimer's Disease," Acta. Biochim. Pol., 51(1), 245 (2004).
144. Kremer, J. J., M. M. Pallitto, D. J. Sklansky, and R. M. Murphy, "Correlation of Beta-Amyloid Aggregate Size and Hydrophobicity with Decreased Bilayer Fluidity of Model Membranes," Biochemistry, 39(33), 10309 (2000).
145. LaFerla, F. M., B. T. Tinkle, C. J. Bieberich, C. C. Haudenschild, and G. Jay, "The Alzheimer's A Beta Peptide Induces Neurodegeneration and Apoptotic Cell Death in Transgenic Mice," Nat. Genet., 9(1), 21 (1995).
146. Lambert, M. P., A. K. Barlow, B. A. Chromy, C. Edwards, R. Freed, M. Liosatos, T. E. Morgan, I. Rozovsky, B. Trommer, K. L. Viola, P. Wals, C. Zhang, C. E. Finch, G. A. Krafft, and W. L. Klein, "Diffusible,
147. Lansbury, P. T., Jr., "Evolution of Amyloid: What Normal Protein Folding May Tell Us About Fibrillogenesis and Disease," Proc. Natl. Acad. Sci. U.S.A., 96(7), 3342 (1999).
148. Le Prince, G., "Alterations of Glial Fibrillary Acidic Protein mRNA Level in the Aging Brain and in Seneile Dementia of the Alzheimer Type," Neuroscience Lett., 151, 71 (1993).
149. Lendon, C. L., A. Martinez, I. M. Behrens, K. S. Kosik, L. Madrigal, J. Norton, R. Neuman, A. Myers, F. Busfield, M. Wragg, M. Arcos, J. C. Arango Viana, J. Ossa, A. Ruiz, A. M. Goate, and F. Lopera, "E280A PS-1 Mutation Causes Alzheimer's Disease but Age of Onset is not Modified by ApoE Alleles," Hum. Mutat., 10(3), 186 (1997).
150. Lewis, J., D. W. Dickson, W. L. Lin, L. Chisholm, A. Corral, G. Jones, S. H. Yen, N. Sahara, L. Skipper, D. Yager, C. Eckman, J. Hardy, M. Hutton, and E. McGowan, "Enhanced Neurofibrillary Degeneration in Transgenic Mice Expressing Mutant Tau and APP," Science, 293(5534), 1487 (2001).
151. Li, W. Y., D. L. Czilli, and L. K. Simmons, "Neuronal Membrane Conductance Activated by Amyloid Beta Peptide: Importance of Peptide Conformation," Brain Res., 682(1-2), 207 (1995).
152. Li, L., S. Zeigler, R. J. Lindsey, and K. Fukuchi, "Effects of an Atherogenic Diet on Amyloidosis in Transgenic Mice Overexpressing the C-Terminal Portion of β-Amyloid Precursor Protein," Soc. Neurosci., 25, 1859 (1999).
153. Lim, G. P., F. Yang, T. Chu, P. Chen, W. Beech, B. Teter, T. Tran, O. Ubeda, K. H. Ashe, S. A. Frautschy, and G. M. Cole, "Ibuprofen Suppresses Plaque Pathology and Inflammation in a Mouse Model for Alzheimer's Disease," J. Neurosci., 20(15), 5709 (2000).
154. 2+-Sensitive Channel in Reconstituted Lipid Vesicles," Biochemistry, 38(34), 11189 (1999).
155. Linder, M. E. and A. G. Gilman, "G Proteins," Sci. Am., 267(1), 56 (1992).
156. Lockhart, B. P., C. Benicourt, J. L. Junien, and A. Privat, "Inhibitors of Free Radical Formation Fail to Attenuate Direct Beta-Amyloid (25-35) Peptide-Mediated Neurotoxicity in Rat Hippocampal Cultures," J. Neurosci. Res., 39(4), 494 (1994).
157. Lomakin, A., D. S. Chung, G. B. Benedek, D. A. Kirschner, and D. B. Teplow, "On the Nucleation and Growth of Amyloid Beta-Protein Fibrils: Detection of Nuclei and Quantitation of Rate Constants," Proc. Natl. Acad. Sci. U.S.A., 93(3), 1125 (1996).
158. Lynn, D. G. and S. C. Meredith, "Review: Model Peptides and the Physicochemical Approach to Beta-Amyloids," J. Struct. Biol., 130(2-3), 153 (2000).
159. Mansfield, S. L., D. A. Jayawickrama, J. S. Timmons, and C. K. Larive, "Measurement of Peptide Aggregation with Pulsed-Field Gradient Nuclear Magnetic Resonance Spectroscopy," Biochim. Biophys. Acta., 1382(2), 257 (1998).
160. 2+ Homeostasis and Cell Death," J. Neurosci., 15(9), 6239 (1995).
161. Markesbery, W. R., "Oxidative Stress Hypothesis in Alzheimer's Disease," Free Radic. Biol. Med., 23(1), 134 (1997).
162. Martins, R. N., P. J. Robinson, J. O. Chleboun, K. Beyreuther, and C. L. Masters, "The Molecular Pathology of Amyloid Deposition in Alzheimer's Disease," Mol Neurobiol, 5(2-4), 389 (1991).
163. Marx, H. H., "The Eilemma of Effectiveness and Economic Value of Alternative Medicine," Gesundheitswesen, 59(5), 297 (1997).
164. Masdeu, J. C., J. L. Zubieta, and J. Arbizu, "Neuroimaging as a Marker of the Onset and Progression of Alzheimer's Disease," J. Neurol. Sci., 236, 55 (2005).
165. Masliah, E., A. Sisk, M. Mallory, L. Mucke, D. Schenk, and D. Games, "Comparison of Neurodegenerative Pathology in Transgenic Mice Overexpressing V717F Beta-Amyloid Precursor Protein and Alzheimer's Disease," J. Neurosci., 16(18), 5795 (1996).
166. Mason, R. P., W. J. Shoemaker, L. Shajenko, and L. G. Herbette, "X-Ray Diffraction Analysis of Brain Lipid Membrane Structure in Alzheimer's Disease and Beta-Amyloid Peptide Interactions," Ann. N. Y. Acad. Sci., 695, 54 (1993).
167. Mason, R. P., R. F. Jacob, M. F. Walter, P. E. Mason, N. A. Avdulov, S. V. Chochina, U. Igbavboa, and W. G. Wood, "Distribution and Fluidizing Action of Soluble and Aggregated Amyloid Beta-Peptide in Rat Synaptic Plasma Membranes," J. Biol. Chem., 274(26), 18801 (1999).
168. Matsuzaki, K. and C. Horikiri, "Interactions of Amyloid Beta-Peptide (1-40) with Ganglioside-Containing Membranes," Biochemistry, 38(13), 4137 (1999).
169. Mattson, M. P., B. Cheng, A. R. Culwell, F. S. Esch, I. Lieberburg, and R. E. Rydel, "Evidence for Excitoprotective and Intraneuronal Calcium-Regulating Roles for Secreted Forms of the Beta-Amyloid Precursor Protein," Neuron, 10(2), 243 (1993).
170. Mattson, M. P. and Y. Goodman, "Different Amyloidogenic Peptides Share a Similar Mechanism of Neurotoxicity Involving Reactive Oxygen Species and Calcium," Brain Res., 676(1), 219 (1995).
171. McLaurin, J., T. Franklin, P. E. Fraser, and A. Chakrabartty, "Structural Transitions Associated with the Interaction of Alzheimer Beta-Amyloid Peptides with Gangliosides," J. Biol. Chem., 273(8), 4506 (1998).
172. Meda, L., P. Baron, and G. Scarlato, "Glial Activation in Alzheimer's Disease: the Role of Abeta and Its Associated Proteins," Neurobiol. Aging., 22(6), 885 (2001).
173. Michaelis, M. L., S. Ansar, Y. Chen, E. R. Reiff, K. I. Seyb, R. H. Himes, K. L. Audus, and G. I. Georg, "{Beta}-Amyloid-Induced Neurodegeneration and Protection by Structurally Diverse Microtubule-Stabilizing Agents," J. Pharmacol. Exp. Ther., 312(2), 659 (2005).
174. Mirzabekov, T., M. C. Lin, W. L. Yuan, P. J. Marshall, M. Carman, K. Tomaselli, I. Lieberburg, and B. L. Kagan, "Channel Formation in Planar Lipid Bilayers by a Neurotoxic Fragment of the Beta-Amyloid Peptide," Biochem. Biophys. Res. Commun., 202(2), 1142 (1994).
175. Mitchell, D. C., M. Straume, J. L. Miller, and B. J. Litman, "Modulation of Metarhodopsin Formation by Cholesterol-Induced Ordering of Bilayer Lipids," Biochemistry, 29(39), 9143 (1990).
176. Miyata, T., R. Inagi, Y. Iida, M. Sato, N. Yamada, O. Oda, K. Maeda, and H. Seo, "Involvement of Beta 2-Microglobulin Modified with Advanced Glycation End Products in the Pathogenesis of Hemodialysis-Associated Amyloidosis. Induction of Human Monocyte Chemotaxis and Macrophage Secretion of Tumor Necrosis Factor-Alpha and Interleukin-1," J. Clin. Invest., 93(2), 521 (1994).
177. Mizuno, T., M. Nakata, H. Naiki, M. Michikawa, R. Wang, C. Haass, and K. Yanagisawa, "Cholesterol-Dependent Generation of a Seeding Amyloid Beta-Protein in Cell Culture," J. Biol. Chem., 274(21), 15110 (1999).
178. Molnar, Z., P. Kovacs, I. Laczko, K. Soos, L. Fulop, B. Penke, and I. Lengyel, "Enhanced G-Protein Activation by a Mixture of Abeta(25-35), Abeta(1-40/42) and Zinc," J. Neurochem., 89(5), 1215 (2004).
179. Morgan, D., D. M. Diamond, P. E. Gottschall, K. E. Ugen, C. Dickey, J. Hardy, K. Duff, P. Jantzen, G. DiCarlo, D. Wilcock, K. Connor, J. Hatcher, C. Hope, M. Gordon, and G. W. Arendash, "A Beta Peptide Vaccination Prevents Memory Loss in an Animal Model of Alzheimer's Disease," Nature, 408(6815), 982 (2000).
180. Muller, W. E., S. Koch, A. Eckert, H. Hartmann, and K. Scheuer, "Beta-Amyloid Peptide Decreases Membrane Fluidity," Brain Res., 674(1), 133 (1995).
181. Muller, W. E., G. P. Eckert, K. Scheuer, N. J. Cairns, A. Maras, and W. F. Gattaz, "Effects of Beta-Amyloid Peptides on the Fluidity of Membranes from Frontal and Parietal Lobes of Human Brain. High Potencies of A Beta 1-42 and A Beta 1-43," Amyloid, 5(1), 10 (1998).
182. Muller, W. E., C. Kirsch, and G. P. Eckert, "Membrane-Disordering Effects of Beta-Amyloid Peptides," Biochem. Soc. Trans., 29(Pt 4), 617 (2001).
183. Murphy, R. M., "Peptide Aggregation in Neurodegenerative Disease," Annu. Rev. Biomed. Eng., 4, 155 (2002).
184. Nagele, R. G., J. Wegiel, V. Venkataraman, H. Imaki, and K. C. Wang, "Contribution of Glial Cells to the Development of Amyloid Plaques in Alzheimer's Disease," Neurobiol. Aging., 25(5), 663 (2004).
185. Naidu, A., D. Quon, and B. Cordell, "Beta-Amyloid Peptide Produced In Vitro is Degraded by Proteinases Released by Cultured Cells," J. Biol. Chem., 270(3), 1369 (1995).
186. Naiki, H. and K. Nakakuki, "First-Order Kinetic Model of Alzheimer's Beta-Amyloid Fibril Extension In Vitro," Lab. Invest., 74(2), 374 (1996).
187. Neufeld, E. B., A. M. Cooney, J. Pitha, E. A. Dawidowicz, N. K. Dwyer, P. G. Pentchev, and E. J. Blanchette-Mackie, "Intracellular Trafficking of Cholesterol Monitored with a Cyclodextrin," J. Biol. Chem., 271(35), 21604 (1996).
188. Nishimoto, I., T. Okamoto, Y. Matsuura, S. Takahashi, Y. Murayama, and E. Ogata, "Alzheimer Amyloid Protein Precursor Complexes with Brain GTP-Binding Protein G(o)," Nature, 362(6415), 75 (1993).
189. Nitsch, R. M., S. A. Farber, J. H. Growdon, and R. J. Wurtman, "Release of Amyloid Beta-Protein Precursor Derivatives by Electrical Depolarization of Rat Hippocampal Slices," Proc. Natl. Acad. Sci. U.S.A., 90(11), 5191 (1993).
190. Nitta, A., T. Fukuta, T. Hasegawa, and T. Nabeshima, "Continuous Infusion of Beta-Amyloid Protein into the Rat Cerebral Ventricle Induces Learning Impairment and Neuronal and Morphological Degeneration," Jpn. J. Pharmacol., 73(1), 51 (1997).
191. Nordstedt, C., J. Naslund, L. O. Tjernberg, A. R. Karlstrom, J. Thyberg, and L. Terenius, "The Alzheimer A Beta Peptide Develops Protease Resistance in Association with Its Polymerization into Fibrils," J. Biol. Chem., 269(49), 30773 (1994).
192. Notkola, I. L., R. Sulkava, J. Pekkanen, T. Erkinjuntti, C. Ehnholm, P. Kivinen, J. Tuomilehto, and A. Nissinen, "Serum Total Cholesterol, Apolipoprotein E Epsilon 4 Allele, and Alzheimer's Disease," Neuroepidemiology, 17(1), 14 (1998).
193. Okamoto, T., S. Takeda, Y. Murayama, E. Ogata, and I. Nishimoto, "Ligand-Dependent G Protein Coupling Function of Amyloid Transmembrane Precursor," J. Biol. Chem., 270(9), 4205 (1995).
194. Pallitto, M. M., J. Ghanta, P. Heinzelman, L. L. Kiessling, and R. M. Murphy, "Recognition Sequence Design for Peptidyl Modulators of Beta-Amyloid Aggregation and Toxicity," Biochemistry, 38(12), 3570 (1999).
195. Pappolla, M. A., Y. J. Chyan, R. A. Omar, K. Hsiao, G. Perry, M. A. Smith, and P. Bozner, "Evidence of Oxidative Stress and In Vivo Neurotoxicity of Beta-Amyloid in a Transgenic Mouse Model of Alzheimer's Disease: A Chronic Oxidative Paradigm for Testing Antioxidant Therapies In Vivo," Am. J. Pathol., 152(4), 871 (1998).
196. Pereira, C., M. S. Santos, and C. Oliveira, "Involvement of Oxidative Stress on the Impairment of Energy Metabolism Induced by A Beta Peptides on PC12 Cells: Protection by Antioxidants," Neurobiol. Dis., 6(3), 209 (1999).
197. Petkova, A. T., G. Buntkowsky, F. Dyda, R. D. Leapman, W. M. Yau, and R. Tycko, "Solid State NMR Reveals a pH-Dependent Antiparallel Beta-Sheet Registry in Fibrils Formed by a Beta-Amyloid Peptide," J. Mol. Biol., 335(1), 247 (2004).
198. Petrella, J. R., R. E. Coleman, and P. M. Doraiswamy, "Neuroimaging and Early Diagnosis of Alzheimer Disease: a Look to the Future," Radiology, 226(2), 315 (2003).
199. Pike, C. J., D. Burdick, A. J. Walencewicz, C. G. Glabe, and C. W. Cotman, "Neurodegeneration Induced by Beta-Amyloid Peptides In Vitro: the Role of Peptide Assembly State," J. Neurosci., 13(4), 1676 (1993).
200. Plant, L. D., J. P. Boyle, I. F. Smith, C. Peers, and H. A. Pearson, "The Production of Amyloid Beta Peptide is a Critical Requirement for the Viability of Central Neurons," J. Neurosci., 23(13), 5531 (2003).
201. Pollard, H. B., N. Arispe, and E. Rojas, "Ion Channel Hypothesis for Alzheimer Amyloid Peptide Neurotoxicity," Cell Mol. Neurobiol., 15(5), 513 (1995).
202. Racchi, M., R. Baetta, N. Salvietti, P. Ianna, G. Franceschini, R. Paoletti, R. Fumagalli, S. Govoni, M. Trabucchi, and M. Soma, "Secretory Processing of Amyloid Precursor Protein is Inhibited by Increase in Cellular Cholesterol Content," Biochem. J., 322(3), 893 (1997).
203. Refolo, L. M., B. Malester, J. LaFrancois, T. Bryant-Thomas, R. Wang, G. S. Tint, K. Sambamurti, K. Duff, and M. A. Pappolla, "Hypercholesterolemia Accelerates the Alzheimer's Amyloid Pathology in a Transgenic Mouse Model," Neurobiol. Dis., 7(4), 321 (2000).
204. Refolo, L. M., M. A. Pappolla, J. LaFrancois, B. Malester, S. D. Schmidt, T. Thomas-Bryant, G. S. Tint, R. Wang, M. Mercken, S. S. Petanceska, and K. E. Duff, "A Cholesterol-Lowering Drug Reduces Beta-Amyloid Pathology in a Transgenic Mouse Model of Alzheimer's Disease," Neurobiol. Dis., 8(5), 890 (2001).
205. 2+-Sensitive Channel," J. Biol. Chem., 273(22), 13379 (1998).
206. Rogaev, E. I., R. Sherrington, E. A. Rogaeva, G. Levesque, M. Ikeda, Y. Liang, H. Chi, C. Lin, K. Holman, and T. Tsuda, "Familial Alzheimer's Disease in Kindreds with Missense Mutations in a Gene on Chromosome 1 Related to the Alzheimer's Disease Type 3 Gene," Nature, 376(6543), 775 (1995).
207. Rogers, J., N. R. Cooper, S. Webster, J. Schultz, P. L. McGeer, S. D. Styren, W. H. Civin, L. Brachova, B. Bradt, P. Ward, "Complement Activation by Beta-Amyloid in Alzheimer Disease," Proc. Natl. Acad. Sci. U.S.A., 89(21), 10016 (1992).
208. Roher, A. E., M. O. Chaney, Y. M. Kuo, S. D. Webster, W. B. Stine, L. J. Haverkamp, A. S. Woods, R. J. Cotter, J. M. Tuohy, G. A. Krafft, B. S. Bonnell, and M. R. Emmerling, "Morphology and Toxicity of Abeta-(1-42) Dimer Derived from Neuritic and Vascular Amyloid Deposits of Alzheimer's Disease," J. Biol. Chem., 271(34), 20631 (1996).
209. Ross, C. A. and M. A. Poirier, "Protein Aggregation and Neurodegenerative Disease," Nat. Med., 10 Suppl, S10 (2004).
210. Roth, G. S., J. A. Joseph, and R. P. Mason, "Membrane Alterations as Causes of Impaired Signal Transduction in Alzheimer's Disease and Aging," Trends Neurosci., 18(5), 203 (1995).
211. Rymer, D. L. and T. A. Good, "The Role of G Protein Activation in the Toxicity of Amyloidogenic Abeta- (1-40), Abeta-(25-35), and Bovine Calcitonin," J. Biol. Chem., 276(4), 2523 (2001).
212. Sadowski, M., J. Pankiewicz, H. Scholtzova, J. A. Ripellino, Y. Li, S. D. Schmidt, P. M. Mathews, J. D. Fryer, D. M. Holtzman, E. M. Sigurdsson, and T. Wisniewski, "A Synthetic Peptide Blocking the Apolipoprotein E/Beta-Amyloid Binding Mitigates Beta-Amyloid Toxicity and Fibril Formation In Vitro and Reduces Beta-Amyloid Plaques in Transgenic Mice," Am. J. Pathol., 165(3), 937 (2004).
213. Saunders, A. M., W. J. Strittmatter, D. Schmechel, P. H. George-Hyslop, M. A. Pericak-Vance, S. H. Joo, B. L. Rosi, J. F. Gusella, D. R. Crapper-MacLachlan, and M. J. Alberts, "Association of Apolipoprotein E Allele Epsilon 4 with Late-Onset Familial and Sporadic Alzheimer's Disease," Neurology, 43(8), 1467 (1993).
214. Saunders, A. M., "Gene Identification in Alzheimer's Disease," Pharmacogenomics, 2(3), 239 (2001).
215. Schellenberg, G. D., "Genetic Dissection of Alzheimer Disease, a Heterogeneous Disorder," Proc. Natl. Acad. Sci. U.S.A., 92(19), 8552 (1995).
216. Schmechel, D. E., A. M. Saunders, W. J. Strittmatter, B. J. Crain, C. M. Hulette, S. H. Joo, M. A. Pericak-Vance, D. Goldgaber, and A. D. Roses, "Increased Amyloid Beta-Peptide Deposition in Cerebral Cortex as a Consequence of Apolipoprotein E Genotype in Late-Onset Alzheimer Disease," Proc. Natl. Acad. Sci. U.S.A., 90(20), 9649 (1993).
217. Schnecko, A., K. Witte, J. Bohl, T. Ohm, and B. Lemmer, "Adenylyl Cyclase Activity in Alzheimer's Disease Brain: Stimulatory and Inhibitory Signal Transduction Pathways are Differently Affected," Brain Res., 644(2), 291 (1994).
218. Schroeder, F., J. R. Jefferson, A. B. Kier, J. Knittel, T. J. Scallen, W. G. Wood, and I. Hapala, "Membrane Cholesterol Dynamics: Cholesterol Domains and Kinetic Pools," Proc. Soc. Exp. Biol. Med., 196(3), 235 (1991).
219. Schuster, D., A. Rajendran, S. W. Hui, T. Nicotera, T. Srikrishnan, and M. L. Kruzel, "Protective Effect of Colostrinin on Neuroblastoma cell Survival is Due to Reduced Aggregation of Beta-Amytoid," Neuropeptides, (2005).
220. Seelig, J., R. Lehrmann, and E. Terzi, "Domain Formation Induced by Lipid-Ion and Lipid-Peptide Interactions," Mol. Membr. Biol., 12(1), 51 (1995).
221. Seilheimer, B., B. Bohrmann, L. Bondolfi, F. Muller, D. Stuber, and H. Dobeli, "The Toxicity of the Alzheimer's Beta-Amyloid Peptide Correlates with a Distinct Fiber Morphology," J. Struct. Biol., 119(1), 59 (1997).
222. Selkoe, D. J., M. B. Podlisny, C. L. Joachim, E. A. Vickers, G. Lee, L. C. Fritz, and T. Oltersdorf, "Beta-Amyloid Precursor Protein of Alzheimer Disease Occurs as 110- to 135-Kilodalton Membrane-Associated Proteins in Neural and Nonneural Tissues," Proc. Natl. Acad. Sci. U.S.A., 85(19), 7341 (1988).
223. Selkoe, D. J., "Biochemistry of Altered Brain Proteins in Alzheimer's Disease," Annu. Rev. Neurosci., 12, 463 (1989).
224. Selkoe, D. J., "Amyloid Protein and Alzheimer's Disease," Sci. Am., 265(5), 68 (1991).
225. Selkoe, D. J., "Amyloid Beta-Protein and the Genetics of Alzheimer's Disease," J. Biol. Chem., 271(31), 18295 (1996).
226. Selkoe, D. J., "Alzheimer's Disease: Genotypes, Phenotypes, and Treatments," Science, 275(5300), 630 (1997).
227. Serpell, L. C., "Alzheimer's Amyloid Fibrils: Structure and Assembly," Biochim. Biophys. Acta., 1502(1), 16 (2000).
228. Shen, C. L. and R. M. Murphy, "Solvent Effects on Self-Assembly of Beta-Amyloid Peptide," Biophys. J., 69(2), 640 (1995).
229. Shie, F. S., R. C. LeBoeuf, J. B. Leverenz, and L. W. Jin, "Effects of Cholesterol Feeding on Histopathologic Hallmarks of Alzheimer's Disease in β-Amyloid Precursor Protein (APP) Transgenic Mice," Soc. Neurosci., 25, 1859 (1999).
230. Shin, R. W., K. Ogino, A. Kondo, T. C. Saido, J. Q. Trojanowski, T. Kitamoto, and J. Tateishi, "Amyloid Beta-Protein (Abeta) 1-40 but not Abeta1-42 Contributes to the Experimental Formation of Alzheimer Disease Amyloid Fibrils in Rat Brain," J. Neurosci., 17(21), 8187 (1997).
231. Simmons, L. K., P. C. May, K. J. Tomaselli, R. E. Rydel, K. S. Fuson, E. F. Brigham, S. Wright, I. Lieberburg, G. W. Becker, and D. N. Brems, "Secondary Structure of Amyloid Beta Peptide Correlates with Neurotoxic Activity In Vitro," Mol. Pharmacol., 45(3), 373 (1994).
232. Simon, M. I., M. P. Strathmann, and N. Gautam, "Diversity of G Proteins in Signal Transduction," Science, 252(5007), 802 (1991).
233. Simons, M., P. Keller, B. De Strooper, K. Beyreuther, C. G. Dotti, and K. Simons, "Cholesterol Depletion Inhibits the Generation of Beta-Amyloid in Hippocampal Neurons," Proc. Natl. Acad Sci. U.S.A., 95(11), 6460 (1998).
234. Singh, I. N., G. Sorrentino, D. S. Sitar, and J. N. Kanfer, "(-) Nicotine Inhibits the Activations of Phospholipases A2 and D by Amyloid Beta Peptide," Brain Res., 800(2), 275 (1998).
235. Sinha, A. K., S. J. Shattil, and R. W. Colman, "Cyclic AMP Metabolism in Cholesterol-Rich Platelets," J. Biol. Chem., 252(10), 3310 (1977).
236. Small, D. H., S. S. Mok, and J. C. Bornstein, "Alzheimer's Disease and Abeta Toxicity: from Top to Bottom," Nat. Rev. Neurosci., 2(8), 595 (2001).
237. Snyder, S. W., U. S. Ladror, W. S. Wade, G. T. Wang, L. W. Barrett, E. D. Matayoshi, H. J. Huffaker, G. A. Krafft, and T. F. Holzman, "Amyloid-Beta Aggregation: Selective Inhibition of Aggregation in Mixtures of Amyloid with Different Chain Lengths," Biophys. J., 67(3), 1216 (1994).
238. Soomets, U., R. Mahlapuu, R. Tehranian, J. Jarvet, E. Karelson, M. Zilmer, K. Iverfeldt, M. Zorko, A. Graslund, and U. Langel, "Regulation of GTPase and Adenylate Cyclase Activity by Amyloid Beta-Peptide and Its Fragments in Rat Brain Tissue," Brain Res., 850(1-2), 179 (1999).
239. Soreghan, B., J. Kosmoski, and C. Glabe, "Surfactant Properties of Alzheimer's A Beta Peptides and the Mechanism of Amyloid Aggregation," J. Biol. Chem., 269(46), 28551 (1994).
240. Soto, C., E. M. Castano, B. Frangione, and N. C. Inestrosa, "The Alpha-Helical to Beta-Strand Transition in the Amino-Terminal Fragment of the Amyloid Beta-Peptide Modulates Amyloid Formation," J. Biol. Chem., 270(7), 3063 (1995).
241. Soto, C., "Alzheimer's and Prion Disease as Disorders of Protein Conformation: Implications for the Design of Novel Therapeutic Approaches," J. Mol. Med., 77(5), 412 (1999).
242. Stein-Behrens, B., K. Adams, M. Yeh, and R. Sapolsky, "Failure of Beta-Amyloid Protein Fragment 25-35 to Cause Hippocampal Damage in the Rat," Neurobiol. Aging, 13(5), 577 (1992).
243. Sticht, H., P. Bayer, D. Willbold, S. Dames, C. Hilbich, K. Beyreuther, R. W. Frank, and P. Rosch, "Structure of Amyloid A4-(1-40)-Peptide of Alzheimer's Disease," Eur. J. Biochem., 233(1), 293 (1995).
244. Stine, W. B., Jr., K. N. Dahlgren, G. A. Krafft, and M. J. LaDu, "In Vitro Characterization of Conditions for Amyloid-Beta Peptide Oligomerization and Fibrillogenesis," J. Biol. Chem., 278(13), 11612 (2003).
245. Sung, Y. J., C. L. Cheng, C. S. Chen, H. B. Huang, F. L. Huang, P. C. Wu, M. S. Shiao, and H. J. Tsay, "Distinct Mechanisms Account for Beta-Amyloid Toxicity in PC12 and Differentiated PC12 Neuronal Cells," J. Biomed. Sci., 10(4), 379 (2003).
246. Szabo, Z., E. Klement, K. Jost, M. Zarandi, K. Soos, and B. Penke, "An FT-IR Study of the Beta-Amyloid Conformation: Standardization of Aggregation Grade," Biochem. Biophys. Res. Commun., 265(2), 297 (1999).
247. Talafous, J., K. J. Marcinowski, G. Klopman, and M. G. Zagorski, "Solution Structure of Residues 1-28 of the Amyloid Beta-Peptide," Biochemistry, 33(25), 7788 (1994).
248. Tandon, A. and P. Fraser, "The Presenilins," Genome Biol., 3(11), Reviews3014 (2002).
249. Tashima, Y., R. Oe, S. Lee, G. Sugihara, E. J. Chambers, M. Takahashi, and T. Yamada, "The Effect of Cholesterol and Monosialoganglioside (GM1) on the Release and Aggregation of Amyloid Beta-Peptide from Liposomes Prepared From Brain Membrane-Llike Lipids," J. Biol. Chem., 279(17), 17587 (2004).
250. Taubes, G., "Misfolding the Way to Disease," Science, 271(5255), 1493 (1996).
251. Taylor, J. P., J. Hardy, and K. H. Fischbeck, "Toxic Proteins in Neurodegenerative Disease," Science, 296(5575), 1991 (2002).
252. Terry, R. D. and R. Katzman, "Senile Dementia of the Alzheimer Type," Ann. Neurol., 14(5), 497 (1983).
253. Terzi, E., G. Holzemann, and J. Seelig, "Alzheimer Beta-Amyloid Peptide 25-35: Electrostatic Interactions with Phospholipid Membranes," Biochemistry, 33(23), 7434 (1994).
254. Terzi, E., G. Holzemann, and J. Seelig, "Self-Association of Beta-Amyloid Peptide (1-40) in Solution and Binding to Lipid Membranes," J. Mol. Biol., 252(5), 633 (1995).
255. Terzi, E., G. Holzemann, and J. Seelig, "Interaction of Alzheimer Beta-Amyloid Peptide(1-40) with Lipid Membranes," Biochemistry, 36(48), 14845 (1997).
256. Tettamanti, G. and L. Riboni, "Gangliosides and Modulation of the Function of Neural Cells," Adv. Lipid. Res., 25, 235 (1993).
257. Tjernberg, L. O., D. J. Callaway, A. Tjernberg, S. Hahne, C. Lilliehook, L. Terenius, J. Thyberg, and C. Nordstedt, "A Molecular Model of Alzheimer Amyloid Beta-Peptide Fibril Formation," J. Biol. Chem., 274(18), 12619 (1999).
258. Tjernberg, L. O., J. Naslund, F. Lindqvist, J. Johansson, A. R. Karlstrom, J. Thyberg, L. Terenius, and C. Nordstedt, "Arrest of Beta-Amyloid Fibril Formation by a Pentapeptide Ligand," J. Biol. Chem., 271(15), 8545 (1996).
259. Tomiyama, T., S. Asano, Y. Suwa, T. Morita, K. Kataoka, H. Mori, and N. Endo, "Rifampicin Prevents the Aggregation and Neurotoxicity of Amyloid Beta Protein In Vitro," Biochem. Biophys. Res. Commun., 204(1), 76 (1994).
260. Tomski, S. J. and R. M. Murphy, "Kinetics of Aggregation of Synthetic Beta-Amyloid Peptide," Arch. Biochem. Biophys., 294(2), 630 (1992).
261. Uversky, V. N. and A. L. Fink, "Conformational Constraints for Amyloid Fibrillation: the Importance of Being Unfolded," Biochim. Biophys. Acta., 1698(2), 131 (2004).
262. Varadarajan, S., S. Yatin, M. Aksenova, and D. A. Butterfield, "Review: Alzheimer's Amyloid Beta-Peptide-Associated free Radical Oxidative Stress and Neurotoxicity [In Process Citation]," J. Struct. Biol., 130(2-3), 184 (2000).
263. Vaudry, D., C. Cottet-Rousselle, M. Basille, A. Falluel-Morel, A. Fournier, H. Vaudry, and B. J. Gonzalez, "Pituitary Adenylate Cyclase-Activating Polypeptide Inhibits Caspase-3 Activity but does not Protect Cerebellar Granule Neurons Against Beta-Amyloid (25-35)-Induced Apoptosis," Regul. Pept., 123(1-3), 43 (2004).
264. Villemagne, V. L., C. C. Rowe, S. Macfarlane, K. E. Novakovic, and C. L. Masters, "Imaginem Oblivionis: the Prospects of Neuroimaging for Early Detection of Alzheimer's Disease," J. Clin. Neurosci., 12(3), 221 (2005).
265. Vitek, M. P., K. Bhattacharya, J. M. Glendening, E. Stopa, H. Vlassara, R. Bucala, K. Manogue, and A. Cerami, "Advanced Glycation End Products Contribute to Amyloidosis in Alzheimer Disease," Proc. Natl. Acad. Sci. U.S.A., 91(11), 4766 (1994).
266. Wakabayashi, M., T. Okada, Y. Kozutsumi, and K. Matsuzaki, "GM1 Ganglioside-Mediated Accumulation of Amyloid Beta-Protein on Cell Membranes," Biochem. Biophys. Res. Commun., 328(4), 1019 (2005).
267. Walsh, D. M., A. Lomakin, G. B. Benedek, M. M. Condron, and D. B. Teplow, "Amyloid Beta-Protein Fibrillogenesis. Detection of a Protofibrillar Intermediate," J. Biol. Chem., 272(35), 22364 (1997).
268. Walsh, D. M., D. M. Hartley, Y. Kusumoto, Y. Fezoui, M. M. Condron, A. Lomakin, G. B. Benedek, D. J. Selkoe, and D. B. Teplow, "Amyloid Beta-Protein Fibrillogenesis. Structure and Biological Activity of Protofibrillar Intermediates," J. Biol. Chem., 274(36), 25945 (1999).
269. Walsh, D. M., I. Klyubin, J. V. Fadeeva, W. K. Cullen, R. Anwyl, M. S. Wolfe, M. J. Rowan, and D. J. Selkoe, "Naturally Secreted Oligomers of Amyloid Beta Protein Potently Inhibit Hippocampal Long-Term Potentiation In Vivo," Nature, 416(6880), 535 (2002).
270. Wang, S. S., D. L. Rymer, and T. A. Good, "Reduction in Cholesterol and Sialic Acid Content Protects Cells from the Toxic Effects of Beta -Amyloid Peptides," J. Biol. Chem., 276(45), 42027 (2001).
271. Wang, S. S., A. Becerra-Arteaga, and T. A. Good, "Development of a Novel Diffusion-Based Method to Estimate the Size of the Aggregated Abeta Species Responsible for Neurotoxicity," Biotechnol. Bioeng., 80(1), 50 (2002).
272. Wang, S. S., V. Kazantzi, and T. A. Good, "A Kinetic Analysis of the Mechanism of Beta-Amyloid Induced G Protein Activation," J. Theor. Biol., 221(2), 269 (2003a).
273. Wang, S. S., S. A. Tobler, T. A. Good, and E. J. Fernandez, "Hydrogen Exchange-Mass Spectrometry Analysis of Beta-Amyloid Peptide Structure," Biochemistry, 42(31), 9507 (2003b).
274. Wang, S. S., T. A. Good, and D. L. Rymer, "The Influence of Phospholipid Membranes on Bovine Calcitonin Peptide's Secondary Structure and Induced Neurotoxic Effects," Int. J. Biochem. Cell. Biol., 37(8), 1656 (2005a).
275. Wang, S. S., T. A. Good, and D. L. Rymer, "The Influence of Phospholipid Membranes on Bovine Calcitonin Secondary Structure and Amyloid Formation," Protein. Sci., 14(6), 1419 (2005b).
276. Wang, S. S.-S., Y. T. Chen, P. H. Chen, and K. N. Liu, "A Kinetic Study on the Aggregation Behavior of Beta-Amyloid Peptides in Different Initial Solvent Environments," Biochem. Eng. J., (2005c).
277. Ward, R. V., K. H. Jennings, R. Jepras, W. Neville, D. E. Owen, J. Hawkins, G. Christie, J. B. Davis, A. George, E. H. Karran, and D. R. Howlett, "Fractionation and Characterization of Oligomeric, Protofibrillar and Fibrillar forms of Beta-Amyloid Peptide," Biochem. J., 348(1), 137 (2000).
278. Webster, S., B. Bonnell, and J. Rogers, "Charge-Based Binding of Complement Component C1q to the Alzheimer Amyloid Beta-Peptide," Am. J. Pathol., 150(5), 1531 (1997).
279. Wegiel, J., K. C. Wang, M. Tarnawski, and B. Lach, "Microglia Cells are the Driving Force in Fibrillar Plaque Formation, Whereas Astrocytes are a Leading Factor in Plague Degradation," Acta. Neuropathol. (Berl), 100(4), 356 (2000).
280. 2+ Channel Blockers Attenuate Beta-Amyloid Peptide Toxicity to Cortical Neurons in Culture," J. Neurochem., 62(1), 372 (1994).
281. Weldon, D. T., S. D. Rogers, J. R. Ghilardi, M. P. Finke, J. P. Cleary, E. O'Hare, W. P. Esler, J. E. Maggio, and P. W. Mantyh, "Fibrillar Beta-Amyloid Induces Microglial Phagocytosis, Expression of Inducible Nitric Oxide Synthase, and Loss of a Select Population of Neurons in the Rat CNS In Vivo," J. Neurosci., 18(6), 2161 (1998).
282. Whitson, J. S., M. P. Mims, W. J. Strittmatter, T. Yamaki, J. D. Morrisett, and S. H. Appel, "Attenuation of the Neurotoxic Effect of A Beta Amyloid Peptide by Apolipoprotein E," Biochem. Biophys. Res. Commun., 199(1), 163 (1994).
283. Whittemore, N. A., R. Mishra, I. Kheterpal, A. D. Williams, R. Wetzel, and E. H. Serpersu, "Hydrogen-Deuterium (H/D) Exchange Mapping of Abeta 1-40 Amyloid Fibril Secondary Structure Using Nuclear Magnetic Resonance Spectroscopy," Biochemistry, 44(11), 4434 (2005).
284. Wiegandt, H., S. Kanda, K. Inoue, K. Utsumi, and S. Nojima, "Studies on the Cell Association of Exogenous Glycolipids," Adv. Exp. Med. Biol., 152, 343 (1982).
285. Williams, A. D., M. Sega, M. Chen, I. Kheterpal, M. Geva, V. Berthelier, D. T. Kaleta, K. D. Cook, and R. Wetzel, "Structural Properties of Abeta Protofibrils Stabilized by a Small Molecule," Proc. Natl. Acad. Sci. U.S.A., 102(20), 7115 (2005).
286. Wood, S. J., R. Wetzel, J. D. Martin, and M. R. Hurle, "Prolines and Amyloidogenicity in Fragments of the Alzheimer's Peptide Beta/A4," Biochemistry, 34(3), 724 (1995).
287. Wood, W. G., G. P. Eckert, U. Igbavboa, and W. E. Muller, "Amyloid Beta-Protein Interactions with Membranes and Cholesterol: Causes or Casualties of Alzheimer's Disease,". Biochimica Et Biophysica Acta-Biomembranes, 1610(2), 281 (2003).
288. Xu, J., S. Chen, S. H. Ahmed, H. Chen, G. Ku, M. P. Goldberg, and C. Y. Hsu, "Amyloid-Beta Peptides are Cytotoxic to Oligodendrocytes," J. Neurosci., 21(1), RC118 (2001).
289. Yamamoto, N., U. Igbabvoa, Y. Shimada, Y. Ohno-Iwashita, M. Kobayashi, W. G. Wood, S. C. Fujita, and K. Yanagisawa, "Accelerated Abeta Aggregation in the Presence of GM1-Ganglioside-Accumulated Synaptosomes of Aged ApoE4-Knock-in Mouse Brain," FEBS Lett., 569(1-3), 135 (2004).
290. Yan, Q., J. H. Zhang, H. T. Liu, S. Babu-Khan, R. Vassar, A. L. Biere, M. Citron, and G. Landreth, "Anti-Inflammatory Drug Therapy Alters Beta-Amyloid Processing and Deposition in an Animal Model of Alzheimer's Disease," J. Neuroscience, 23(20), 7504 (2003).
291. Yanagisawa, K., A. Odaka, N. Suzuki, and Y. Ihara, "GM1 Ganglioside-Bound Amyloid Beta-Protein (A Beta): A Possible form of Preamyloid in Alzheimer's Disease [see comments]," Nat. Med., 1(10), 1062 (1995).
292. Yanagisawa, K. A. Asami-Odaka, N. Suzuki, and Y. Ihara, "Fractionation of Amyloid Beta-Protein (A Beta) in Alzheimer's Disease and Down's Syndrome Brains. Presence of Membrane-Bound A Beta," Ann. N. Y. Acad. Sci., 786, 184 (1996).
293. Yanagisawa, K. and Y. Ihara, "GM1 Ganglioside-Bound Amyloid Beta-Protein in Alzheimer's Disease Brain," Neurobiol. Aging, 19(1 Suppl), S65 (1998).
294. Yankner, B. A., L. I. Benowitz, L. Villa-Komaroff, and R. L. Neve, "Transfection of PC12 Cells with the Human GAP-43 Gene: Effects on Neurite Outgrowth and Regeneration," Brain Res. Mol. Brain Res., 7(1), 39 (1990).
295. Yatin, S. M., M. Aksenov, and D. A. Butterfield, "The Antioxidant Vitamin E Modulate Amyloid Beta-Peptide-Induced Creatine Kinase Activity Inhibition and Increased Protein Oxidation: Implications for the Free Radical Hypothesis of Alzheimer's Disease," Neurochem. Res., 24(3), 427 (1999a).
296. Yatin, S. M., S. Varadarajan, C. D. Link, and D. A. Butterfield, "In Vitro and In Vivo Oxidative Stress Associated with Alzheimer's Amyloid Beta-Peptide (1-42)," Neurobiol. Aging, 20(3), 325 (1999b).
297. Yeagle, P. L., "Modulation of Membrane Function by Cholesterol," Biochimie, 73(10), 1303 (1991).
298. 2+-and Cholinergic Receptor-Mediated Phosphoinositide Degradation by Alteration of Membrane and Cytosolic Phospholipase C in Brain Cortex," Neurochem. Res., 25(2), 189 (2000).
299. Zekanowski, C., D. Religa, C. Graff, S. Filipek, and J. Kuznicki, "Genetic Aspects of Alzheimer's Disease," Acta. Neurobiol. Exp. (Wars), 64(1), 19 (2004).
300. Zhang, C., H. E. Qiu, G. A. Krafft, and W. L. Klein, "Protein Kinase C and F-Actin are Essential for Stimulation of Neuronal FAK Tyrosine Phosphorylation by G-proteins and Amyloid Beta Protein," FEBS Lett., 386(2-3), 185 (1996).
301. Zhang, Q., E. T. Powers, J. Nieva, M. E. Huff, M. A. Dendle, J.